Quinidine and Mitapivat: Interaction Details
- Quinidine
- CardioquinCin-QuinDuraquin +6 more
- Mitapivat
- PyrukyndAqvesme
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Quinidine and Mitapivat interaction:
Quinidine
- Cardioquin
- Cin-Quin
- Duraquin
- Quinact
- Quinaglute
- Quinalan
- Quinatime
- Quinidex
- Quinora
What Happens When You Take Quinidine With Mitapivat
What can happen when they are taken together (rated Major)
Reduced exposure
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Mitapivat should not be used together with sensitive CYP3A substrates that have a . Because mitapivat induces CYP3A, giving it with a sensitive CYP3A substrate lowers the exposure to that substrate.1
When cannot be avoided, patients should be monitored for loss of therapeutic effect. In interaction studies with midazolam, a sensitive CYP3A substrate, mitapivat 5 mg twice daily lowered midazolam (inf) by 21% and by 19%, mitapivat 20 mg twice daily lowered them by 43% and 39%, and mitapivat 50 mg twice daily lowered them by 57% and 52%, respectively.3 At mitapivat 100 mg twice daily, the reductions in midazolam AUC (inf) and Cmax were 65% and 59%, respectively.1
The Quinidine and Mitapivat Interaction, Explained
Mitapivat can lower the amount of quinidine in your body. Mitapivat speeds up an enzyme () that helps break down quinidine, so quinidine may clear faster and work less well. Quinidine is a heart rhythm medicine, and the right level in the blood matters a lot, so even a small drop can be important.
This does not mean you should stop or change anything on your own. Keep taking both as prescribed and tell your pharmacist or doctor you use both. Your care team can watch you more closely for loss of effect, such as heart rhythm symptoms returning, and can tailor your dose if needed.
Mechanism: Mitapivat is a ; quinidine is a (main route of ). increases clearance and reduces quinidine exposure, risking loss of antiarrhythmic . Quinidine is active as given (not a for this purpose) and has a , so modest changes matter.
- Magnitude: Data are from midazolam: reduced 21% (5 mg BID) to 65% (100 mg BID), 19% to 59%, dose dependent. Quinidine-specific data are not given.
- Evidence: probable; onset unspecified.
- Management: Labeling advises avoiding sensitive narrow-TI CYP3A substrates. If is required, monitor for loss of therapeutic effect (consider and quinidine concentrations), and individualize the dose.
See the 3 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Quinidine and Mitapivat Interact
The likely mechanism
of -mediated by mitapivat
How to Manage the Quinidine and Mitapivat Interaction
The documented advice is to avoid this combination when possible. If your care team decides you need both, they can monitor you for loss of quinidine's effect and may adjust and individualize the dose.
- Keep taking both medicines exactly as prescribed unless told otherwise.
- Tell your pharmacist and prescriber about both drugs, including any dose change of mitapivat.
- Report returning symptoms such as palpitations, dizziness, or fainting promptly.
- Your team may monitor you more closely, especially when doses change.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Quinidine or Mitapivat need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: PYRUKYND oral tablets, mitapivat oral tablets
In drug interaction studies, coadministering mitapivat with midazolam (a sensitive ) lowered midazolam (inf) and , respectively, by 21% and 19% at a mitapivat dose of 5 mg twice daily, by 43% and 39% at 20 mg twice daily, and by 57% and 52% at 50 mg twice daily.2 In a similar finding, midazolam AUC (inf) and Cmax were reduced by 65% and 59%, respectively, with mitapivat 100 mg twice daily.1
Quinidine and Mitapivat: Common Questions
How serious is the Quinidine and Mitapivat interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Quinidine and Mitapivat interaction managed?
The documented advice is to avoid this combination when possible. If your care team decides you need both, they can monitor you for loss of quinidine's effect and may adjust and individualize the dose. Keep taking both medicines exactly as prescribed unless told otherwise. Tell your pharmacist and prescriber about both drugs, including any dose change of mitapivat. Report returning symptoms such a… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Quinidine and Mitapivat Interaction
Ask in your own words about taking Quinidine and Mitapivat together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (3)
- Product Information: AQVESME™ oral tablets, mitapivat oral tablets. Agios Pharmaceuticals Inc (per FDA), Cambridge, MA, 2025. DailyMed
- Product Information: PYRUKYND(R) oral tablets, mitapivat oral tablets. Agios Pharmaceuticals Inc (per FDA), Cambridge, MA, 2025. DailyMed
- Product Information: PYRUKYND(R) oral tablets, mitapivat oral tablets. Agios Pharmaceuticals Inc (per FDA), Cambridge, MA, 2022. DailyMed
Other Serious Interactions of Quinidine and Mitapivat
Also serious with Quinidine
- ColchicineContraindicated
- Ketoconazole TopicalContraindicated
- LefamulinContraindicated
- DronedaroneContraindicated
Also serious with Mitapivat
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Quinidine
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- WineMajor
- American HelleboreMajor
- ArsenicMajor
- BeerMajor
- CesiumMajor
- + 203 more
With Mitapivat
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- Vitamin EModerate
- GingerModerate
- TurmericModerate
- Black PepperModerate
- GrapeModerate
- + 151 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.